[1]刘明明 马勇 许海燕 郭杨 吕南宁 程建△.加味六味地黄汤治疗肝肾亏虚型糖尿病性骨质疏松症的临床疗效[J].中国中医骨伤科杂志,2022,30(03):12-16.
　LIU Mingming MA Yong XU Haiyan GUO Yang LYU Nanning CHENG Jian.Clinical Efficacy of Jiawei Liuwei Dihuang Decoction Combined with Alendronate on the Treatment of Diabetic Osteoporosis with Liver-Kidney Depletion Pattern[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2022,30(03):12-16.
点击复制

加味六味地黄汤治疗肝肾亏虚型糖尿病性骨质疏松症的临床疗效()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第30卷
期数:
2022年03期
页码:
12-16
栏目:
临床研究
出版日期:
2022-03-15

文章信息/Info

Title:
Clinical Efficacy of Jiawei Liuwei Dihuang Decoction Combined with Alendronate on the Treatment of Diabetic Osteoporosis with Liver-Kidney Depletion Pattern
文章编号:
1005-0205(2022)03-0012-05
作者:
刘明明1 马勇2 许海燕3 郭杨2 吕南宁1 程建4△
1徐州医科大学连云港临床学院/连云港市第二人民医院(江苏 连云港,222003)2南京中医药大学附属医院3徐州医科大学基础医学院4徐州市中心医院/南京中医药大学附属徐州市中心医院
Author(s):
LIU Mingming1 MA Yong2 XU Haiyan3 GUO Yang2 LYU Nanning1 CHENG Jian4△
1Lianyungang Clinical College of Xuzhou Medical University, Lianyungang 222003, Jiangsu China; 2Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210004, China; 3Basic Medical College of Xuzhou Medical University, Xuzhou 221004, Jiangsu China; 4Xuzhou Central Hospital, Xuzhou 221009, Jiangsu China.
关键词:
加味六味地黄汤;  阿仑膦酸钠;  糖尿病性骨质疏松症;  肝肾亏虚证;  骨代谢
Keywords:
Jiawei Liuwei Dihuang decoction;  alendronate;  diabetic osteoporosis;  liver-kidney depletion pattern;  bone metabolism
分类号:
R274.39
文献标志码:
A
摘要:
目的:探讨应用加味六味地黄汤治疗肝肾亏虚型糖尿病性骨质疏松症患者的临床疗效。方法:将2018年6月至2020年6月收治的60例糖尿病性骨质疏松症患者随机分为两组,每组30例。对照组中男16例,女14例,口服阿仑膦酸钠片治疗; 观察组中男14例,女16例,口服加味六味地黄汤治疗。两组患者均常规口服碳酸钙,疗程为4个月,分析比较两组患者治疗前后的疼痛视觉模拟评分(VAS)、健康调查简表(SF-36)评分、糖脂代谢、骨代谢及骨密度等相关指标。结果:两组患者治疗后VAS评分均较治疗前有改善,差异有统计学意义(P<0.05),但两组间改善程度差异无统计学意义(P>0.05); 两组患者治疗后SF-36评分、糖代谢及骨代谢指标均较治疗前好转,差异有统计学意义(P<0.05),同时观察组改善情况较对照组更好,差异有统计学意义(P<0.05); 两组患者治疗后脂代谢及骨密度较治疗前差异无统计学意义(P>0.05)。结论:加味六味地黄汤治疗肝肾亏虚型糖尿病性骨质疏松症,可以改善机体骨代谢和糖代谢,减轻腰背部疼痛,提高患者生活质量,较单纯口服阿仑膦酸钠片效果更佳。
Abstract:
Objective:To explore the clinical efficacy of Jiawei Liuwei Dihuang decoction combined with alendronate on the treatment of diabetic osteoporosis with liver-kidney depletion.Methods:60 patients with diabetic osteoporosis from June 2018 to June 2020 were randomly divided into two groups with 30 patients in each group.In the control group 16 males and 14 females were treated with oral alendronate.In the observation group 14 males and 16 females were treated with Jiawei Liuwei Dihuang decoction.All patients were treated with calcium carbonate orally.The treatment course in both groups was 4 months, and then the visual analogue scale(VAS), short form 36-item health survey(SF-36)score, glucose and lipid metabolism, bone mineral density and bone metabolism were compared between the two groups before and after treatment.Results:The WAS scores of the two groups after treatment were significantly improved than those before treatment(P<0.05), but there was no significant difference in the degree of improvement between the two groups(P>0.05).The SF-36 score, glucose metabolism and bone metabolism of the two groups were significantly improved after treatment(P<0.05), and the improvement of the observation group was more obvious than that of control group, and the difference was statistically significant(P<0.05).There was no significant difference in lipid metabolism and bone mineral density between the two groups after treatment(P>0.05).Conclusion:The application of Jiawei Liuwei Dihuang decoction combined with alendronate on the treatment of diabetic osteoporosis with liver-kidney depletion can effectively improve bone metabolism and glucose metabolism, reduce low back pain and improve the quality of life of patients, which is better than oral alendronate alone.

参考文献/References:

[1] 王杰,杨宝辉,李浩鹏.骨质疏松性腰椎椎体压缩性骨折的危险因素分析[J].中国中医骨伤科杂志,2021,29(8):29-33.
[2] PISCITELLI P,NEGLIA C,VIGILANZA A,et al.Diabetes and bone:biological and environmental factors[J].Curr Opin Endocrinol Diabetes Obes,2015,22(6):439-445.
[3] MOHSIN S,KAIMALA S,SUNNY J J,et al.Type 2 diabetes mellitus increases the risk to hip fracture in postmenopausal osteoporosis by deteriorating the trabecular bone microarchitecture and bone mass[J].J Diabetes Res,2019:3876957.
[4] 朱丽华,张贤.糖尿病骨质疏松中医病机探析[J].中国中医骨伤科杂志,2011,19(2):57-58.
[5] 程建,蔡建平,吴晓东,等.糖尿病并发骨质疏松症的中医临床经验[J].现代中西医结合杂志,2020,29(23):2619-2622.
[6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志,2021,37(4):311-318.
[7] 张智海,刘忠厚,李娜,等.中国人骨质疏松症诊断标准专家共识(第三稿·2014版)[J].中国骨质疏松杂志,2014,20(9):1007-1010.
[8] 宗行万之助.疼痛的估价——用特殊的视觉模拟评分法作参考(VAS)[J].疼痛学杂志,1994(4):153.
[9] 李鲁,王红妹,沈毅.SF-36健康调查量表中文版的研制及其性能测试[J].中华预防医学杂志,2002(2):38-42.
[10] 林广劲,陈乐.2型糖尿病合并骨质疏松症患者骨代谢指标变化研究[J].临床医学工程,2021,28(1):87-88.
[11] 麻红艳,叶山东.老年男性2型糖尿病患者骨质疏松相关因素分析[J].中华疾病控制杂志,2017,21(7):688-692.
[12] FIXEN C W,FIXEN D R.Managing and maintaining bone mineral density in diabetes patients with pharmacotherapy[J].Expert Opin Pharmacother,2017,18(18):2001-2006.
[13] SCHWARTZ A V.Epidemiology of fractures in type 2 diabetes[J].Bone,2016,82:2-8.
[14] RATHMANN W,KOSTEV K.Fracture risk in patientswith newly diagnosed type 2 diabetes:a retrospective database analysis in primary care[J].J Diabetes Complications,2015,29(6):766-770.
[15] 胡治勇,崔龙,董晓颖,等.糖尿病患者骨质疏松评估、危险因素及相关机制的研究进展[J].重庆医学,2020,49(4):660-664.
[16] 邓拥军.老年性2型糖尿病患者骨代谢指标分析[J].中国中医骨伤科杂志,2010,18(11):19-20.
[17] LEE H S,HWANG J S.Impact of type 2 diabetes mellitus and antidiabetic medications on bone metabolism[J].Curr Diab Rep,2020,20(12):78.
[18] 陈玉华,戴芳芳.糖尿病性骨质疏松症致病因素相关性分析[J].中国骨质疏松杂志,2021,27(5):641-645.
[19] 郭小双,郑剑南,曹俊青,等.六味地黄丸配合阿仑膦酸钠治疗肝肾阴虚型绝经后骨质疏松症的临床研究[J].湖北中医药大学学报,2018,20(2):82-84.
[20] 史晓林,王和鸣,高毅,等.绝经后骨质疏松症(骨痿)中医药诊疗指南(2019年版)[J].中医正骨,2020,32(2):1-13.
[21] 朱琦琦,戴芳芳.糖尿病性骨质疏松症的中医研究进展[J].中国骨质疏松杂志,2019,25(9):1331-1335.
[22] LIU M M,DONG R,HUA Z,et al.Therapeutic potentialof Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis[J].Biosci Rep,2020,40(9):BSR20201778.

备注/Memo

备注/Memo:
基金项目:江苏省自然科学基金(BK20180996)江苏省中医药局一般项目(YB201964)连云港市卫健委课题面上项目(201915)
△通信作者 E-mail:drchengjian@126.com
更新日期/Last Update: 1900-01-01